Biostax Corp.
BTAX
$0.0002
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -65.27% | 13.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -62.57% | 13.08% | |||
| Operating Income | 62.57% | -13.08% | |||
| Income Before Tax | 91.54% | -26.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 91.54% | -26.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 91.54% | -26.97% | |||
| EBIT | 62.57% | -13.08% | |||
| EBITDA | 65.51% | -13.78% | |||
| EPS Basic | 92.16% | -27.50% | |||
| Normalized Basic EPS | 90.63% | -28.00% | |||
| EPS Diluted | 96.00% | -150.00% | |||
| Normalized Diluted EPS | 90.63% | -28.00% | |||
| Average Basic Shares Outstanding | 0.09% | -0.02% | |||
| Average Diluted Shares Outstanding | 0.09% | -2.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||